Ozempic is a brand-name medication that contains semaglutide and is FDA-approved for type 2 diabetes
And the digital health company Noom announced Thursday that it is expanding its weight-loss drug offerings to include pills, starting with metformin
Les injections : le smaglutide ( Wegovy ) et le liraglutide ( Saxenda ) Le smaglutide et le liraglutide sont des principes actifs qui imitent laction du GLP-1
Some patients progress through dose increases every 4 weeks
Pregnancy, Planned Pregnancy, and Breastfeeding The label states plainly that weight loss offers no benefit to a pregnant patient and may cause fetal harm, and directs that Wegovy be discontinued in pregnant patients using it for weight reduction
( 10.1530/EO-23-0015) [DOI] [PMC free article] [PubMed] [Google Scholar] 13.Ungvari Z, Bartha A, Ungvari A, et al